Data is not available at this time.
CareTech Holdings PLC operates as a specialized provider of care and support services in the UK, catering to children and adults with complex needs. The company’s diversified portfolio spans four segments: Adults Services, Children’s Services, Foster Care, and Digital Technology. Its Adult Services segment focuses on residential care for individuals with learning disabilities, mental health conditions, and physical impairments, while the Children’s Services segment delivers tailored care and education for young people with behavioral challenges. The Foster Care division provides mainstream and specialist foster placements, and the Digital Technology segment enhances accessibility through assistive communication tools. CareTech’s vertically integrated model ensures end-to-end support, positioning it as a leader in the UK’s fragmented care sector. The company’s emphasis on high-quality, regulated services strengthens its reputation among local authorities and private clients. Its niche focus on complex care needs differentiates it from broader healthcare providers, allowing for premium pricing and long-term contracts. With a growing demand for specialized care due to demographic trends and regulatory tailwinds, CareTech is well-placed to capitalize on sector consolidation and outsourcing by public bodies.
CareTech reported revenue of £489.1 million for FY2021, reflecting steady demand across its service lines. Net income stood at £31.9 million, with diluted EPS of 29p, indicating moderate profitability in a cost-intensive sector. Operating cash flow of £83.8 million underscores efficient working capital management, though capital expenditures of £31.9 million highlight ongoing investments in facilities and technology.
The company’s earnings are supported by recurring revenue from long-term care contracts, providing stability despite sector margin pressures. Capital efficiency is tempered by high operational costs inherent to regulated care services, though its asset-light foster care segment contributes higher returns. Debt servicing costs are manageable, given the defensive nature of cash flows.
CareTech’s balance sheet shows £65.6 million in cash against £443.9 million of total debt, suggesting leveraged but sustainable liquidity. The debt load is typical for the capital-intensive care sector, with cash flows sufficient to cover obligations. Regulatory compliance and staffing costs remain key balance sheet considerations.
Growth is driven by organic demand and selective acquisitions, particularly in specialist care. The dividend payout of 118.3p per share signals confidence in cash flow stability, though reinvestment needs may limit aggressive increases. Sector tailwinds, such as aging populations and outsourcing trends, support long-term expansion.
The stock’s low beta (0.31) reflects its defensive profile, though the lack of disclosed market cap limits valuation analysis. Investors likely prize its recession-resistant model and dividend yield, balanced against regulatory risks and labor cost inflation.
CareTech’s deep expertise in complex care and strategic acquisitions fortify its market position. Challenges include staffing shortages and regulatory scrutiny, but its focus on high-margin niches and technology integration offers resilience. The outlook remains stable, with growth tied to public sector partnerships and demographic demand.
Company filings, London Stock Exchange data
show cash flow forecast
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |